These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38184316)

  • 1. Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru: a retrospective cohort study.
    Bravo-Zúñiga J; Chávez-Gómez R; Soto-Becerra P
    BMJ Open; 2024 Jan; 14(1):e076217. PubMed ID: 38184316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
    Ali I; Donne RL; Kalra PA
    BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.
    Lennartz CS; Pickering JW; Seiler-Mußler S; Bauer L; Untersteller K; Emrich IE; Zawada AM; Radermacher J; Tangri N; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):609-15. PubMed ID: 26787778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort.
    Irish GL; Cuthbertson L; Kitsos A; Saunder T; Clayton PA; Jose MD
    Nephrology (Carlton); 2023 Jun; 28(6):328-335. PubMed ID: 37076122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.
    Kwek JL; Pang HQJ; Li H; Lim WWL; Choo JCJ; Choong HL; Foo MWY; Chan CM
    Singapore Med J; 2022 Jun; 63(6):313-318. PubMed ID: 36043308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts.
    Grams ME; Brunskill NJ; Ballew SH; Sang Y; Coresh J; Matsushita K; Surapaneni A; Bell S; Carrero JJ; Chodick G; Evans M; Heerspink HJL; Inker LA; Iseki K; Kalra PA; Kirchner HL; Lee BJ; Levin A; Major RW; Medcalf J; Nadkarni GN; Naimark DMJ; Ricardo AC; Sawhney S; Sood MM; Staplin N; Stempniewicz N; Stengel B; Sumida K; Traynor JP; van den Brand J; Wen CP; Woodward M; Yang JW; Wang AY; Tangri N
    J Am Soc Nephrol; 2023 Mar; 34(3):482-494. PubMed ID: 36857500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models.
    Ramspek CL; Teece L; Snell KIE; Evans M; Riley RD; van Smeden M; van Geloven N; van Diepen M
    Int J Epidemiol; 2022 May; 51(2):615-625. PubMed ID: 34919691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.
    Thanabalasingam SJ; Iliescu EA; Norman PA; Day AG; Akbari A; Hundemer GL; White CA
    Kidney Med; 2022 Apr; 4(4):100440. PubMed ID: 35445190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
    Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
    Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.
    Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E
    JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validation study of the 4-variable and 8-variable kidney failure risk equation in transplant recipients in the United Kingdom.
    Ali I; Kalra PA
    BMC Nephrol; 2021 Feb; 22(1):57. PubMed ID: 33563222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the kidney failure risk equation in a Portuguese cohort.
    da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
    Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study.
    Maher F; Teece L; Major RW; Bradbury N; Medcalf JF; Brunskill NJ; Booth S; Gray LJ
    Diagn Progn Res; 2023 Oct; 7(1):22. PubMed ID: 37798742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.
    Wang Y; Nguyen FNHL; Allen JC; Lew JQL; Tan NC; Jafar TH
    BMC Nephrol; 2019 Dec; 20(1):451. PubMed ID: 31801468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.
    Ramspek CL; Evans M; Wanner C; Drechsler C; Chesnaye NC; Szymczak M; Krajewska M; Torino C; Porto G; Hayward S; Caskey F; Dekker FW; Jager KJ; van Diepen M;
    J Am Soc Nephrol; 2021 May; 32(5):1174-1186. PubMed ID: 33685974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.
    Hundemer GL; Tangri N; Sood MM; Ramsay T; Bugeja A; Brown PA; Clark EG; Biyani M; White CA; Akbari A
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1424-1432. PubMed ID: 32928746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of end-stage kidney disease risk prediction in an ethnically diverse cohort of people with type 2 diabetes: use of kidney failure risk equation.
    Goubar A; Mangelis A; Thomas S; Fountoulakis N; Collins J; Ayis S; Karalliedde J
    BMJ Open Diabetes Res Care; 2024 Sep; 12(4):. PubMed ID: 39277182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD.
    Hundemer GL; Tangri N; Sood MM; Clark EG; Canney M; Edwards C; White CA; Oliver MJ; Ramsay T; Akbari A
    Kidney Int Rep; 2021 Dec; 6(12):2993-3001. PubMed ID: 34901569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.